Misaligned Pharmacy Incentives in Value-Based Care
JAMA · 2024
DOI: 10.1001/jama.2024.8140 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, 2024. Verfasst von Nina Jain und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Hauptthemen laut MEDLINE: Pharmaceutical Services, Reimbursement, Incentive, Value-Based Purchasing, Pharmaceutical Preparations. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
This Viewpoint explains some ways in which the alignment of incentives between payers and clinicians in value-based care (VBC) arrangements can be interrupted and proposes a multifaceted approach to realigning incentives for drug spending within VBC contracts to better provide value-based care and improve patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
- Harvard Medical School, Boston, Massachusetts.
- Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Zitieren
APA
Jain, N., Rome, B. N., & Mendu, M. L. (2024). Misaligned Pharmacy Incentives in Value-Based Care. JAMA. https://doi.org/10.1001/jama.2024.8140
Vancouver
Jain N, Rome BN, Mendu ML. Misaligned Pharmacy Incentives in Value-Based Care. JAMA. 2024. doi:10.1001/jama.2024.8140
BibTeX
@article{Jain2024,
author = {Jain, Nina and Rome, Benjamin N and Mendu, Mallika L},
title = {Misaligned Pharmacy Incentives in Value-Based Care},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.8140}
}
EUVIMED